Genesis Drug Discovery & Development (GD3)

  • Booth: 1620

Genesis Drug Discovery and Development (GD3) is a preclinical CRO offering a comprehensive portfolio of services to ensure the efficient development and coordination of unique preclinical programs, from discovery through candidate selection. Services include advanced in vivo testing capabilities in biochemical & molecular biology, creation and testing of patient-derived cancer xenograft models, synthetic organic, & medicinal chemistry, and small molecule drug target validation.

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".